(ANSA) – ROME, June 06 – New data have shown encouraging results of the molecule cabozantinib in monotherapy and in combination in different types of cancer, including metastatic non-small cell lung cancer (NSCLC). This is evidenced by various studies presented at the Congress of the American Society of Clinical Oncology (ASCO).
“Currently, first-line immunotherapy with or without chemotherapy is the standard of care for patients with metastatic NSCLC, but there is a real need for further effective treatment options for those patients who progress after previous immunotherapy,” he said. Santiago Ponce-Aix, Head of Drug Development Department, Institute Gustave Roussy, France, and researcher in COSMIC-021 – These new data are encouraging as they show the potential role of cabozantinib in creating an environment that can increase activity in combination. with the atezolizumab molecule in NSCLC.
We await further data evaluating this combination for this patient population where such a high unmet medical need remains. “
“The therapeutic potential of cabozantinib as a treatment option against a wide range of cancers, including NSCLC, continues to be evaluated and these data demonstrate our ambition to offer meaningful new treatments to patients. These latest findings support the role that cabozantinib can play a role in positively impacting treatment when paired with immunotherapy, and we will continue to evaluate cabozantinib both alone and in combination with other innovative therapies for more difficult-to-treat cancers, “said Howard Mayer, Executive Vice President and Head of Research and Development by Ipsen. (HANDLE).
breaking latest news © Copyright ANSA
<![CDATA[]]>
var userAccept = $.cookie(‘cb-enabled’);
var cookieAccepted = (userAccept != null && userAccept.indexOf(‘accepted’) != -1);
if (cookieAccepted) {
(function($n,e,o,d,a,t,a$) {
$n._4wRecom = $n._4wRecom || {};
$n._4wRecom.Q = $n._4wRecom.Q || [];
$n._4wRecom.Q.push([‘setup’, function () {
$n._4wRecom.T.setTaxonomy(“/ansa/ansa/ansa.it/ambiente”);
$n._4wRecom.B.addPosition(“ansa_ansa_ambiente”,”NeoWidget”);
}]);
var x = d.createElement(e), s = d.getElementsByTagName(e)[0];
x.src = (‘https:’ == t.protocol ? ‘https://js-ssl’ : ‘http://js’)+o;
x.async = a;
s.parentNode.insertBefore(x, s);
}) (window,’scr’+’ipt’,’.neodatagroup.com/4wr.js’,document,1,location,1);
}
<![CDATA[]]>
<![CDATA[]]>